Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 6:20 PM View:  | Agilent Technologies Inc. (A) | 15-Mar-24 | Grant | 1,678 | $147.48 | $247,471.00 | 42% 4.03K to 5.71K | (2%) |
| 29-Feb-24 6:53 AM View: | Pfizer Inc. (PFE) | 28-Feb-24 | Payment of Exercise | 21,437 | $27.04 | $579,656.00 | (6%) 345.15K to 323.71K | |
| 27-Feb-24 1:46 PM View: | Pfizer Inc. (PFE) | 23-Feb-24 | Payment of Exercise | 24,822 | $27.76 | $689,059.00 | (7%) 369.97K to 345.15K | |
| 20-Mar-23 9:38 PM View: | Agilent Technologies Inc. (A) | 16-Mar-23 | Grant | 1,658 | $136.82 | $226,848.00 | 70% 2.36K to 4.02K | 6% |
| 28-Feb-23 8:24 AM View: | Pfizer Inc. (PFE) | 25-Feb-23 | Payment of Exercise | 37,078 | $41.75 | $1,548,010.00 | (9%) 393.1K to 356.03K | |
| 24-Feb-23 8:18 PM View: | Pfizer Inc. (PFE) | 22-Feb-23 | Payment of Exercise | 32,592 | $42.38 | $1,381,250.00 | (8%) 425.7K to 393.1K | |
| 09-Nov-22 4:08 PM View: | Pfizer Inc. (PFE) | 07-Nov-22 | Option Exercise | 79,108 | $33.21 | $2,627,260.00 | 23% 342.75K to 421.86K | |
| 12-May-22 4:34 PM View: | Pfizer Inc. (PFE) | 11-May-22 | Market Sale | 63,902 | $49.32 | $3,151,550.00 | (16%) 399.06K to 335.16K | (14%) |
| 21-Mar-22 5:06 PM View: | Agilent Technologies Inc. (A) | 17-Mar-22 | Grant | 1,785 | $136.82 | $244,224.00 | 315% 0.57K to 2.35K | 6% |
| 04-Mar-22 4:13 PM View: | Pfizer Inc. (PFE) | 03-Mar-22 | Option Exercise | 102,460 | $31.83 | $3,261,040.00 | 35% 295.94K to 398.4K | |
| 01-Mar-22 4:01 PM View: | Pfizer Inc. (PFE) | 26-Feb-22 | Payment of Exercise | 29,744 | $47.72 | $1,419,380.00 | (9%) 325.68K to 295.94K | |
| 25-Feb-22 6:40 PM View: | Pfizer Inc. (PFE) | 23-Feb-22 | Payment of Exercise | 29,767 | $46.87 | $1,395,180.00 | (8%) 355.45K to 325.68K | |
| 21-Dec-21 6:31 PM View: | Pfizer Inc. (PFE) | 17-Dec-21 | Option Exercise | 71,187 | $30.17 | $2,147,710.00 | 25% 282.25K to 353.44K | |
| 15-Nov-21 5:40 PM View: | Pfizer Inc. (PFE) | 11-Nov-21 | Option Exercise | 199,548 | $25.13 | $5,014,930.00 | 141% 141.76K to 341.31K | |
| 15-Nov-21 5:40 PM View: | Pfizer Inc. (PFE) | 11-Nov-21 | Market Option Sale | 59,664 | $50.29 | $3,000,650.00 | (17%) 341.31K to 281.64K | |
| 23-Sep-21 10:00 PM View: | Agilent Technologies Inc. (A) | 22-Sep-21 | Grant | 567 | $172.44 | $97,773.50 | 100% 0 to 0.57K | (< 1%) |
| 02-Mar-21 7:00 PM View: | Pfizer Inc. (PFE) | 27-Feb-21 | Payment of Exercise | 23,841 | $33.49 | $798,435.00 | (15%) 163.33K to 139.49K | (< 1%) |
| 01-Mar-21 4:01 PM View: | Pfizer Inc. (PFE) | 25-Feb-21 | Payment of Exercise | 28,271 | $33.82 | $956,125.00 | (15%) 186.6K to 158.33K | < 1% |
| 19-May-20 5:37 PM View: | Pfizer Inc. (PFE) | 18-May-20 | Market Sale | 95,353 | $37.78 | $3,602,680.00 | (35%) 271.98K to 176.62K | 3% |
| 03-Mar-20 12:54 PM View: | Pfizer Inc. (PFE) | 28-Feb-20 | Payment of Exercise | 39,446 | $33.42 | $1,318,290.00 | (13%) 309.65K to 270.2K | (9%) |
| 28-Feb-20 7:17 PM View: | Pfizer Inc. (PFE) | 26-Feb-20 | Grant | 45,566 | -- | -- | 15% 301.88K to 347.44K | |
| 28-Feb-20 7:17 PM View: | Pfizer Inc. (PFE) | 26-Feb-20 | Payment of Exercise | 37,792 | $34.72 | $1,312,140.00 | (11%) 347.44K to 309.65K | (5%) |
| 05-Mar-19 4:54 PM View: | Pfizer Inc. (PFE) | 04-Mar-19 | Market Option Sale | 5,720 | $43.53 | $248,963.00 | (2%) 339.83K to 334.11K | 18% |
| 05-Mar-19 4:54 PM View: | Pfizer Inc. (PFE) | 04-Mar-19 | Market Sale | 43,362 | $43.53 | $1,887,330.00 | (13%) 334.11K to 290.75K | 18% |
| 05-Mar-19 4:54 PM View: | Pfizer Inc. (PFE) | 01-Mar-19 | Option Exercise | 106,191 | $31.34 | $3,328,060.00 | 32% 334.11K to 440.3K | |
| 05-Mar-19 4:54 PM View: | Pfizer Inc. (PFE) | 01-Mar-19 | Market Option Sale | 100,471 | $43.56 | $4,376,850.00 | (23%) 440.3K to 339.83K | 18% |
| 01-Mar-19 7:29 PM View: | Pfizer Inc. (PFE) | 27-Feb-19 | Grant | 96,183 | -- | -- | 31% 311.7K to 407.89K | |
| 01-Mar-19 7:29 PM View: | Pfizer Inc. (PFE) | 27-Feb-19 | Payment of Exercise | 73,773 | $42.93 | $3,167,080.00 | (18%) 407.89K to 334.11K | 17% |
| 26-Feb-19 10:00 PM View: | Pfizer Inc. (PFE) | 23-Feb-19 | Payment of Exercise | 54,568 | $42.96 | $2,344,240.00 | (15%) 366.27K to 311.7K | 17% |
| 01-Feb-19 7:28 PM View: | Pfizer Inc. (PFE) | 31-Jan-19 | Option Exercise | 125,968 | $29.78 | $3,751,420.00 | 53% 237.71K to 363.68K | |
| 17-Sep-18 4:08 PM View: | Pfizer Inc. (PFE) | 13-Sep-18 | Option Exercise | 181,712 | $24.56 | $4,462,170.00 | 335% 54.19K to 235.9K | |
| 12-Mar-18 5:01 PM View: | Pfizer Inc. (PFE) | 09-Mar-18 | Market Sale | 69,699 | $36.59 | $2,550,390.00 | (57%) 122.46K to 52.76K | 6% |
| 05-Mar-18 9:23 AM View: | Pfizer Inc. (PFE) | 02-Mar-18 | Market Sale | 13,986 | $35.85 | $501,398.00 | (10%) 136.44K to 122.46K | 4% |
| 02-Mar-18 3:24 PM View: | Pfizer Inc. (PFE) | 28-Feb-18 | Payment of Exercise | 158,482 | $35.85 | $5,681,080.00 | (54%) 294.92K to 136.44K | 4% |
| 02-Mar-18 3:24 PM View: | Pfizer Inc. (PFE) | 28-Feb-18 | Option Exercise | 198,238 | $27.37 | $5,425,770.00 | 205% 96.69K to 294.92K | |
| 28-Feb-18 6:04 PM View: | Pfizer Inc. (PFE) | 27-Feb-18 | Market Sale | 64,587 | $37.04 | $2,392,310.00 | (40%) 161.27K to 96.69K | 7% |
| 28-Feb-18 6:04 PM View: | Pfizer Inc. (PFE) | 26-Feb-18 | Grant | 86,086 | -- | -- | 73% 117.34K to 203.43K | |
| 28-Feb-18 6:04 PM View: | Pfizer Inc. (PFE) | 26-Feb-18 | Payment of Exercise | 42,157 | $37.09 | $1,563,600.00 | (21%) 203.43K to 161.27K | 7% |
| 27-Feb-18 7:32 PM View: | Pfizer Inc. (PFE) | 24-Feb-18 | Payment of Exercise | 109,493 | $36.12 | $3,954,660.00 | (48%) 226.84K to 117.34K | 5% |
| 27-Feb-18 7:32 PM View: | Pfizer Inc. (PFE) | 24-Feb-18 | Option Exercise | 174,081 | $18.90 | $3,290,130.00 | 330% 52.76K to 226.84K | |
| 03-Mar-17 4:06 PM View: | Pfizer Inc. (PFE) | 02-Mar-17 | Market Sale | 15,401 | $34.55 | $532,105.00 | (23%) 66.23K to 50.83K | 2% |
| 03-Mar-17 4:06 PM View: | Pfizer Inc. (PFE) | 01-Mar-17 | Market Sale | 15,569 | $34.48 | $536,819.00 | (19%) 81.8K to 66.23K | 2% |
| 01-Mar-17 5:10 PM View: | Pfizer Inc. (PFE) | 27-Feb-17 | Grant | 31,800 | -- | -- | 22% 141.83K to 173.63K | |
| 01-Mar-17 5:10 PM View: | Pfizer Inc. (PFE) | 27-Feb-17 | Payment of Exercise | 32,981 | $34.28 | $1,130,590.00 | (19%) 173.63K to 140.65K | 1% |
| 01-Mar-17 5:10 PM View: | Pfizer Inc. (PFE) | 27-Feb-17 | Market Sale | 58,846 | $34.26 | $2,016,240.00 | (42%) 140.65K to 81.8K | 1% |
| 27-Feb-17 6:21 PM View: | Pfizer Inc. (PFE) | 23-Feb-17 | Payment of Exercise | 159,600 | $33.02 | $5,269,930.00 | (53%) 301.43K to 141.83K | (2%) |
| 27-Feb-17 6:21 PM View: | Pfizer Inc. (PFE) | 23-Feb-17 | Option Exercise | 218,447 | $21.03 | $4,593,940.00 | 263% 82.98K to 301.43K | |
| 05-May-16 5:29 PM View: | Pfizer Inc. (PFE) | 04-May-16 | Market Sale | 67,588 | $33.46 | $2,261,560.00 | (15%) 439.67K to 372.08K | (5%) |
| 01-Mar-16 7:12 PM View: | Pfizer Inc. (PFE) | 28-Feb-16 | Grant | 18,530 | -- | -- | 4% 427.69K to 446.22K | |
| 01-Mar-16 7:12 PM View: | Pfizer Inc. (PFE) | 28-Feb-16 | Payment of Exercise | 9,549 | $30.23 | $288,666.00 | (2%) 446.22K to 436.67K | (16%) |